Noninvasive Characterization of Tumor Angiogenesis and Oxygenation in Bevacizumab-treated Recurrent Glioblastoma by Using Dynamic Susceptibility MRI: Secondary Analysis of the European Organization for Research and Treatment of Cancer 26101 Trial-Reference-Cited by-同舟云学术

Noninvasive Characterization of Tumor Angiogenesis and Oxygenation in Bevacizumab-treated Recurrent Glioblastoma by Using Dynamic Susceptibility MRI: Secondary Analysis of the European Organization for Research and Treatment of Cancer 26101 Trial

Published:2020-10 Issue:1 Volume:297 Page:164-175
ISSN:0033-8419
Container-title:Radiology
language:en
Short-container-title:Radiology

Author:

Kickingereder Philipp^ORCID,Brugnara Gianluca^ORCID,Hansen Mikkel Bo^ORCID,Nowosielski Martha^ORCID,Pflüger Irada,Schell Marianne,Isensee Fabian^ORCID,Foltyn Martha^ORCID,Neuberger Ulf^ORCID,Kessler Tobias^ORCID,Sahm Felix^ORCID,Wick Antje^ORCID,Heiland Sabine^ORCID,Weller Michael^ORCID,Platten Michael^ORCID,von Deimling Andreas,Maier-Hein Klaus H.^ORCID,Østergaard Leif^ORCID,van den Bent Martin J.^ORCID,Gorlia Thierry,Wick Wolfgang^ORCID,Bendszus Martin

Funder

Deutsche Forschungsgemeinschaft

Publisher

Radiological Society of North America (RSNA)

Subject

Radiology, Nuclear Medicine and imaging

Link

http://pubs.rsna.org/doi/pdf/10.1148/radiol.2020200978

Reference32 articles.

1. Bevacizumab Alone and in Combination With Irinotecan in Recurrent Glioblastoma

2. Phase II Trial of Single-Agent Bevacizumab Followed by Bevacizumab Plus Irinotecan at Tumor Progression in Recurrent Glioblastoma

3. Bevacizumab plus Radiotherapy–Temozolomide for Newly Diagnosed Glioblastoma

4. A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of prognostic imaging biomarkers in H3 K27-altered diffuse midline gliomas in adults: impact of tumor oxygenation imaging biomarkers on survival;Neuroradiology;2024-07-16

2. Clinical, qualitative imaging biomarkers, and tumor oxygenation imaging biomarkers for differentiation of midline-located IDH wild-type glioblastomas and H3 K27-altered diffuse midline gliomas in adults;European Journal of Radiology;2024-04

3. Standardized brain tumor imaging protocols for clinical trials: current recommendations and tips for integration;Frontiers in Radiology;2023-12-13

4. A Review on the Use of Imaging Biomarkers in Oncology Clinical Trials: Quality Assurance Strategies for Technical Validation;Tomography;2023-10-17

5. Relative cerebral blood volume as response predictor in the treatment of recurrent glioblastoma with anti-angiogenic therapy;Clinical Neurology and Neurosurgery;2023-10